【Neuronetics Inc(STIM)投资者维权信息】
2021年10月12日Neuronetics Inc(STIM)公布了初步收入结果,预计第三季度的总收入约为 1380 万美元,而此前发布的指导为 1500 万美元至 1600 万美元。公司还下调了全年收入指引,预计 2021 财年在 5,330 万美元至 5,430 万美...查看全文
蹊之美股生物医药2021-08-04 23:10
作者:林出
微信公众号:蹊之美股生物医药 / CaesarBiotech
Gainers:
Arcturus Therapeutics (NASDAQ:ARCT) +68%
Flora Growth (NASDAQ:FLGC) +62%
Translate Bio (NASDAQ:TBIO) +29%
Outlook Therapeutics (NASDAQ:OTLK) +6%
Losers:
Neuronet...查看全文
$Neuronetics(STIM)$ 8-K Current report, items 1.01, 2.03, and 9.01 Accession Number: 0001193125-20-121141 Act: 34 Size: 84 KB 网页链接
$Neuronetics(STIM)$ 8-K Current report, items 2.05, 5.02, and 9.01 Accession Number: 0001193125-20-105356 Act: 34 Size: 85 KB 网页链接
$Neuronetics(STIM)$ DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material Accession Number: 0001564590-20-016433 Act: 34 Size: 191 KB 网页链接
$Neuronetics(STIM)$ DEF 14A Other definitive proxy statements Accession Number: 0001564590-20-016431 Act: 34 Size: 1 MB 网页链接
$Neuronetics(STIM)$ 8-K Current report, items 2.02 and 9.01 Accession Number: 0001193125-20-102105 Act: 34 Size: 33 KB 网页链接
$Neuronetics(STIM)$ 8-A12B Registration of securities [Section 12(b)] Accession Number: 0001193125-20-101482 Act: 34 Size: 17 KB 网页链接
$Neuronetics(STIM)$ 8-K Current report, items 1.01, 3.03, 5.03, 8.01, and 9.01 Accession Number: 0001564590-20-015935 Act: 34 Size: 500 KB 网页链接
$Neuronetics(STIM)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001192482-20-000236 Size: 6 KB 网页链接
$Neuronetics(STIM)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001192482-20-000228 Size: 5 KB 网页链接
$Neuronetics(STIM)$ 内部交易: 2020-03-10,Sr. VP, GC, CCO and Secretary,MACAN WILLIAM ANDREW ,买入,5000普通股, $2.00